Skip to main content

Table 2 Cardiovascular Diseases (CVDs) risk factors of study population in three phases of Isfahan cohort study

From: Longitudinal association between an overall diet quality index and latent profiles of cardiovascular risk factors: results from a population based 13-year follow up cohort study

CVDs risk factors Assessed variables Levels Phases of study Adjusted P value for trend
2001 2007 2013
Plasma glucose FBG Mean ± SD 87.74 ± 31.1 99.73 ± 35.85 107.1 ± 38.95  < 0.0011
Normal (< 110) 2570 (91.2%) 2345 (82.6%) 1101 (75.2%)  < 0.0012
Borderline (110–126) 87 (3.1%) 169 (6.0%) 137 (9.4%)
Impaired (≥ 126) 160 (5.7%) 326 (11.5%) 226 (15.4%)
Blood pressure SBP/DBP Mean ± SD 120.22/77.67 ± 20.54/11.42 123.28/76.73 ± 19.83/11.62 128.36/83.64 ± 17.59/10.31  < 0.0011
Normal (≤ 120/80) 1744 (61.9%) 1546 (54.4%) 563 (38.5%)  < 0.0012
Borderline (120/80–140/90) 453 (16.1%) 573 (20.2%) 362 (24.7%)
Impaired (≥ 140/90) 620 (22.0%) 721 (25.4%) 539 (36.8%)
Serum lipids TG Mean ± SD 173.38 ± 78.8 172.97 ± 111.67 155.59 ± 89.83  < 0.0011
Normal (< 150) 1238 (43.9%) 1469 (51.7%) 854 (58.3%)  < 0.0012
Borderline (150–200) 690 (24.5%) 539 (19.0%) 328 (22.4%)
Impaired (≥ 200) 889 (31.6%) 832 (29.3%) 282 (19.3%)
LDL-C Mean ± SD 130.36 ± 42.11 124.14 ± 30.1 111.07 ± 27.76  < 0.0011
Normal (< 130) 1456 (51.7%) 1691 (59.5%) 1114 (76.1%)  < 0.0012
Borderline (130–160) 720 (25.6%) 814 (28.7%) 288 (19.7%)
Impaired (≥ 160) 641 (22.8%) 335 (11.8%) 62 (4.2%)
HDL-C Mean ± SD 46.71 ± 10.11 45.89 ± 11.16 43.62 ± 10.88  < 0.0011
Normal (> 60) 288 (10.2%) 288 (10.1%) 75 (5.1%)  < 0.0012
Borderline (40–60) 1775 (63.0%) 1692 (59.6%) 845 (57.7%)
Impaired (< 40) 754 (26.8%) 860 (30.3%) 544 (37.2%)
Anthropometric indices BMI Mean ± SD 26.57 ± 4.65 27.41 ± 4.39 27.96 ± 4.7  < 0.0011
Normal (< 25) 1114 (39.5%) 865 (30.5%) 400 (27.3%)  < 0.0012
Borderline (25–30) 1119 (39.7%) 1226 (43.2%) 622 (42.5%)
Impaired (≥ 30) 584 (20.7%) 749 (26.4%) 442 (30.2%)
WC
(female/male)
Mean ± SD 94.11 ± 12.23 94.25 ± 11.37 97.31 ± 11.09  < 0.0011
Normal (< 80 / < 94) 975 (34.6%) 934 (32.9%) 333 (22.7%)  < 0.0012
Borderline (80–88/94–102) 547 (19.4%) 590 (20.8%) 328 (22.4%)
Impaired (> 88 / > 102) 1295 (46.0%) 1316 (46.3%) 803 (54.8%)
Laboratory inflammatory state hs-CRP Mean ± SD 3.28 ± 1.51 4.97 ± 3.78 3.12 ± 4.38  < 0.0011
Normal (< 1) 115 (4.1%) 407 (14.3%) 735 (50.2%)  < 0.0012
Borderline (1–3) 1357 (48.2%) 726 (25.6%) 336 (23.0%)
Impaired (> 3) 1345 (47.7%) 1707 (60.1%) 393 (26.8%)
Number of impaired CVDs risk factors (Impaired level vs. Borderline and Normal levels) 0 290 (10.29) 250 (8.8) 173 (11.82)  < 0.0012
1 811 (28.79) 774 (27.25) 439 (29.99)
2 992 (35.21) 927 (32.64) 443 (30.26)
3 535 (18.99) 628 (22.11) 292 (19.95)
4 169 (6) 225 (7.92) 105 (7.17)
5 20 (0.71) 36 (1.27) 12 (0.82)
  1. FBG: Fasting Blood Glucose; SBP/DBP: Systolic/ Diastolic Blood Pressure; TG: Triglycerides; LDL-C: Low-Density Lipoprotein cholesterol; HDL-C: High-Density Lipoprotein cholesterol; BMI: Body Mass Index; WC: Waist Circumference; hs-CRP: high sensitivity C-Reactive Protein
  2. 1P value obtained from linear mixed model adjusted for sex and age
  3. 2P value obtained from mixed effect ordered logistic regression model adjusted for sex and age